Inventor · disambiguated record
Bertrand L. Chenard
Also filed as: CHENARD BERTRAND L · CHENARD BERTRAND LEO
67 granted patents·33 pending applications·1,000 citations·filing 1984–2024
99Inventor score
Top patents by PatentIndex Score
100 records- 0192US6821985B2Pharmaceutical combinations for the treatment of stroke and traumatic brain injuryPFIZER·Filed 2001·Granted Nov 23, 2004·65 cites·11 claims
- 0292US6667317B2Pharmaceutical combinations for the treatment of stroke and traumatic brain injuryPFIZER·Filed 2001·Granted Dec 23, 2003·60 cites·15 claims
- 0391US6627755B1Quinazolin-4-one AMPA antagonistsPFIZER·Filed 1998·Granted Sep 30, 2003·56 cites·8 claims
- 0491US5597826ACompositions containing sertraline and a 5-HT1D receptor agonist or antagonistPFIZER·Filed 1994·Granted Jan 28, 1997·97 cites·13 claims
- 0591US5498610ANeuroprotective indolone and related derivativesPFIZER·Filed 1994·Granted Mar 12, 1996·43 cites·7 claims
- 0690US7342115B23-substituted-6-aryl pyridinesNEUROGEN CORP·Filed 2003·Granted Mar 11, 2008·35 cites·33 claims
- 0790US5710168A2-piperidino-1-alkanol derivatives as neuroprotective agentsPFIZER·Filed 1994·Granted Jan 20, 1998·39 cites·18 claims
- 0889US6921764B2Thieno-pyrimidin-4-one AMPA antagonistsPFIZER·Filed 2003·Granted Jul 26, 2005·22 cites·15 claims
- 0989US5272160A2-piperidino-1-alkanol derivatives as antiischemic agentsPFIZER·Filed 1992·Granted Dec 21, 1993·37 cites·13 claims
- 1088US9359359B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2014·Granted Jun 7, 2016·7 cites·21 claims
- 1188US8003656B22-phenoxy pyrimidinone analoguesNEUROGEN CORP·Filed 2007·Granted Aug 23, 2011·10 cites·10 claims
- 1287US7253168B2Substituted 1-benzyl-4-substituted piperazine analoguesNEUROGEN CORP·Filed 2005·Granted Aug 7, 2007·13 cites·26 claims
- 1385US5185343ANortropyl-1-alkanol derivatives as antiischemic agentsPFIZER·Filed 1990·Granted Feb 9, 1993·21 cites·10 claims
- 1485US2025034143A1Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1584US7488740B2Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2004·Granted Feb 10, 2009·17 cites·48 claims
- 1683US6136812AMethods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapyPFIZER·Filed 1998·Granted Oct 24, 2000·61 cites·10 claims
- 1782US7935702B2Substituted biaryl quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2005·Granted May 3, 2011·6 cites·10 claims
- 1882US6136861ABicyclo[2.2.1]heptanes and related compoundsPFIZER·Filed 1999·Granted Oct 24, 2000·52 cites·23 claims
- 1982US5594007AMethod for treating spinal cord trauma with phenolic 2-piperidino-1-alkanolsPFIZER·Filed 1994·Granted Jan 14, 1997·23 cites·1 claims
- 2081US10221177B2Inhibiting the transient receptor potential A1 ion channelHYDRA BIOSCIENCES INC·Filed 2015·Granted Mar 5, 2019·3 cites·22 claims
- 2180US10399982B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2018·Granted Sep 3, 2019·1 cites·5 claims
- 2280US6124361ABicyclo[3.1.0]hexanes and related compoundsPFIZER·Filed 1998·Granted Sep 26, 2000·20 cites·11 claims
- 2379US11807621B2Compounds and compositions for use in treating skin disordersKAMARI PHARMA LTD·Filed 2021·Granted Nov 7, 2023·1 cites·27 claims
- 2479US9969736B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2017·Granted May 15, 2018·1 cites·2 claims
- 2579US7863454B23-substituted-6-aryl pyridinesNOVARTIS INT PHARM LTD·Filed 2008·Granted Jan 4, 2011·3 cites·4 claims
- 2679US6258827B1Combinations for the treatment of parkinsonism containing selective NMDA antagonistsPFIZER·Filed 1995·Granted Jul 10, 2001·43 cites·5 claims
- 2778US11208409B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES LLC·Filed 2019·Granted Dec 28, 2021·1 cites·12 claims
- 2877US11958854B2Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES LLC·Filed 2021·Granted Apr 16, 2024·0 cites·12 claims
- 2976US10519158B2Inhibiting the transient receptor potential A1 ion channelLILLY CO ELI·Filed 2018·Granted Dec 31, 2019·1 cites·20 claims
- 3076US7662830B2Substituted biaryl piperazinyl-pyridine analoguesNEUROGEN CORP·Filed 2005·Granted Feb 16, 2010·2 cites·6 claims
- 3175US5962457A2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-onesPFIZER·Filed 1997·Granted Oct 5, 1999·38 cites·40 claims
- 3274US7186734B2Aryl imidazoles and related compounds as C5a receptor modulatorsNEUROGEN CORP·Filed 2003·Granted Mar 6, 2007·6 cites·36 claims
- 3372US6958351B2NMDA NR2B antagonists for treatmentPFIZER·Filed 2001·Granted Oct 25, 2005·5 cites·2 claims
- 3470US8119665B2Aryl imidazoles and related compounds as C5a receptor modulatorsLUKE GEORGE P·Filed 2007·Granted Feb 21, 2012·2 cites·13 claims
- 3570US6323208B1Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-onesPFIZER·Filed 1998·Granted Nov 27, 2001·28 cites·16 claims
- 3670US5391742AIntermediates for 2-piperidino-1-alkanolsPFIZER·Filed 1994·Granted Feb 21, 1995·8 cites·6 claims
- 3770US5338754A2-pyrrolidino-1-alkanol derivatives as antiischemic agentsPFIZER·Filed 1993·Granted Aug 16, 1994·17 cites·12 claims
- 3869US12435061B2Compounds and compositions for use in treating skin disordersKAMARI PHARMA LTD·Filed 2023·Granted Oct 7, 2025·0 cites·44 claims
- 3969US12152014B2Therapeutic compounds and compositionsEXLTHERA PHARMACEUTICALS INC·Filed 2023·Granted Nov 26, 2024·0 cites·18 claims
- 4069US10428072B2Inhibiting the transient receptor potential A1 ion channelLILLY CO ELI·Filed 2018·Granted Oct 1, 2019·1 cites·58 claims
- 4169US4723016APreparation of anhydrous organic acid saltsDU PONT·Filed 1986·Granted Feb 2, 1988·10 cites·37 claims
- 4269US2023270731A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4368US6060479AQuinazoline-4-one AMPA antagonistsPFIZER·Filed 1998·Granted May 9, 2000·25 cites·20 claims
- 4468US5306723ANeuroprotective indolone and related derivativesPFIZER·Filed 1991·Granted Apr 26, 1994·21 cites·55 claims
- 4567US6046213ANeuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivativesPFIZER·Filed 1995·Granted Apr 4, 2000·25 cites·23 claims
- 4665US6380204B1Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditionsPFIZER·Filed 1998·Granted Apr 30, 2002·22 cites·13 claims
- 4765US2021361634A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4863US7271170B2Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligandsNEUROGEN CORP·Filed 2004·Granted Sep 18, 2007·1 cites·190 claims
- 4960US6303615B12,3 disubstituded-4(3H)-quinazolinonesPFIZER·Filed 1997·Granted Oct 16, 2001·18 cites·20 claims
- 5060US2016237089A1Substituted xanthines and methods of use thereofHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bertrand L. Chenard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →